gennova biopharmaceuticals

Phase I Trial For Leishmaniasis Vaccine Underway

A vaccine against one of the most neglected yet fatal tropical diseases is being tested for the first time in a clinical trial in India and the United States.

First Vaccine Against Fatal Visceral Leishmaniasis Enters Phase I Trial

As the disease expands its global reach, the Infectious Disease Research Institute teams up with India and the Gates Foundation to target the most deadly form of leishmaniasis.